Accumulated Other Comprehensive (Loss) Income

12 Months Ended

Dec. 31, 2016

Equity [Abstract]

Accumulated Other Comprehensive (Loss) Income

Accumulated Other Comprehensive (Loss) Income

The following table provides a reconciliation of the components of accumulated other comprehensive (loss) income, net of tax, attributable to The Medicines Company:

	Foreign currency translation adjustment			Unrealized (gain) loss on available for sale securities			Total
	(In thousands)
Balance at January 1, 2014	$	(4,701	)	$	49		$	(4,652	)
Other comprehensive income before reclassifications	7,180			—			7,180
Total other comprehensive loss	7,180			—			7,180
Balance at December 31, 2014	$	2,479		$	49		$	2,528
Other comprehensive income before reclassifications	1,445			—			1,445
Total other comprehensive income	1,445			—			1,445
Balance at December 31, 2015	$	3,924		$	49		$	3,973
Other comprehensive income before reclassifications	213			—			213
Amounts reclassified from accumulated other comprehensive income(1) (2)	(9,616		)	(49		)	(9,665		)
Total other comprehensive income	(9,403		)	(49		)	(9,452		)
Balance at December 31, 2016	$	(5,479	)	$	—		$	(5,479	)

_______________________________________

(1) Amounts were reclassified to other income in the accompanying consolidated statements of operations. There is generally no tax impact related to foreign currency translation adjustments, as earnings are considered permanently reinvested. In addition, there were no material tax impacts related to unrealized gains or losses on available for sale securities in the periods presented.

(2) See Note 24, “Discontinued Operations,” for a discussion of this reclass of foreign currency translation adjustment.